Article

Visionary genomics focus of 2011 Association for Research in Vision and Ophthalmology meeting

Under the theme of "Visionary Genomics," researchers and clinicians will gather at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology in May in Fort Lauderdale, FL, to explore how genomic technology is leading to new understanding of vision health, disease and treatment.

For program highlights, go to http://www.arvo.org/am/, which is also the online home to everything you need to know about the following annual meeting activities.

Abstract submissions for the annual meeting will close Dec. 3. If you are an ARVO member, check out the Call to Abstracts and Program highlights insert mailed to you with the Summer-Fall issue of ARVONews for additional information, or go to http://www.arvo.org/am/ to download a copy.

ARVO education courses will take place Saturday, April 30. Interested participants must register for these courses separate from-and in advance of-the annual meeting registration. Online registration for educational courses will open November 1.

Full-day courses

Thyroid Associated Eye Disease: Multidisciplinary Update of Pathogenesis, New Directions for Collaborative Research: a course that brings together experts from multiple disciplines including ophthalmology, endocrinology, medicine, and pathology to give a broad overview of the field and serve as a step-off point for establishing new approaches for studying thyroid eye disease.

Designing and Managing Clinical Trials in Eye Research: a course tailored specifically for vision and eye researchers in the early stages of their careers to enhance understanding of current issues, state-of-the-art approaches to problems in clinical trials, and how to conduct a trial in ophthalmology.

Half-day topics

Continuing medical education (CME) credits are offered for CME-eligible annual meeting sessions. ARVO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.